China National Accord Medicines Corporation Ltd. announced unaudited earnings results for the first quarter ended March 31, 2016. For the quarter, the company reported operating income of RMB 7,053,846,519.17 compared to RMB 6,261,714,700.23 a year ago. Net profit attributable to shareholders of the company was RMB 199,027,472.31 compared to RMB 197,026,237.82 a year ago.

Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was RMB 187,445,696.09 compared to RMB 192,315,542.07 a year ago. Net cash outflow from operating activities of RMB 100,461,465.99 compared to net cash flows from operating activities of RMB 182,179,606.70 a year ago. Diluted earnings per share was RMB 0.549 compared to RMB 0.543 a year ago.

Weighted average ROE was 3.58% compared to 4.05% a year ago.